Cue Biopharma (CUE) Other Working Capital Changes (2017 - 2025)

Cue Biopharma has disclosed Other Working Capital Changes across 9 years of filings, most recently posting -$4.9 million for Q4 2025.

• Other Working Capital Changes for Q4 2025 came in at -$4.9 million, down 100.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.6 million (down 29.44% YoY), and the FY2025 annual result was -$2.6 million, down 29.44% from the prior year.
• Other Working Capital Changes came in at -$4.9 million for Q4 2025 at Cue Biopharma, down from $764000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $6.4 million in Q4 2021 to a low of -$6.3 million in Q3 2021.
• The 5-year median for Other Working Capital Changes is $1500.0 (2022), against an average of -$34520.0.
• Across the five-year window, Other Working Capital Changes surged 1565.57% in 2021 and sank 786.32% in 2023, its largest moves.
• Cue Biopharma's Other Working Capital Changes stood at $6.4 million in 2021, then slumped by 113.71% to -$880000.0 in 2022, then soared by 380.11% to $2.5 million in 2023, then tumbled by 198.54% to -$2.4 million in 2024, then slumped by 100.95% to -$4.9 million in 2025.
• The last three Other Working Capital Changes figures came in at -$4.9 million (Q4 2025), $764000.0 (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.